AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Aidoc’s $150 Million Round Shows Investors Still See Room to Scale Radiology AI
Aidoc has raised $150 million from Goldman Sachs and other investors, adding fresh fuel to one of the best-known names in radiology AI. The financing suggests capital is still available for vendors that can show clinical traction, platform breadth, and a credible path to enterprise scale. The raise also comes with signs of IPO ambition, putting Aidoc in the small group of healthcare AI firms trying to translate product momentum into a public-market narrative.
Biotech IPO Window Reopens as AI Becomes a Core Drug-Development Narrative
A BioSpace report suggests biotech IPO activity is improving, with AI playing a more central role in how companies position themselves to public investors. The shift matters because it indicates AI is no longer just a scientific story inside R&D teams, but a capital-markets story shaping how biotech companies raise money and explain future productivity.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.